Colon cancer: Two genetic alterations that generate metastases
09.10.2014 - Press release
With approximately 42,000 estimated new cases in France in 2012, colon cancer is, for both sexes combined, the third most common type of cancer, and the second most common cause of cancer deaths after lung cancer. ...
New resistance mechanisms to melanoma targeted therapies : contribution of the translation of RNAs into proteins
28.07.2014 - Press release
French investigators have discovered new resistance mechanisms to targeted therapies used for less than three years in the treatment of melanoma. This discovery enables us not only to better understand why these treatments become ineffective but also to reveal new avenues for ...
Radiotherapy ‘flashes’ to reduce side effects
21.07.2014 - Press release
Treating hard and fast seems to be a good way to limit the side effects of radiotherapy. This is the discovery made by researchers at the Curie Institute, Inserm and the Vaud University Hospital, published in Science Translational Medicine on 16 July. Radiotherapy ...
Cancer: life two years after diagnosis
10.06.2014 - Press release
(Français) L’Institut national du cancer (INCa) et l’Inserm présentent, lors d’un colloque de restitution le 10 juin, les résultats d’une enquête de grande envergure interrogeant 4349 personnes atteintes d’un cancer deux ans après le diagnostic. Appelée VICAN2 pour « Vie après le ...
Metastases: Tumour Cell Dissemination
30.04.2014 - Press release
Carine Rossé, INSERM research fellow and Philippe Chavrier, Research Director at CNRS, working alongside Dr. Anne Vincent-Salomon, medical researcher at the Institut Curie, have recently discovered one of the mechanisms that allow triple negative breast cancer cells to exit the mammary gland. ...
Stopping the vicious circle of tumour progression in children with bone cancer
20.03.2014 - Press release
Researchers in Inserm Unit 957 "Bone Resorption Physiopathology and Primary Bone Tumour Therapy" in Nantes have recently developed an innovative treatment which stops the vicious circle that allows bone cancer to progress. ...